Cambridge Trust’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $676K | Hold |
11,500
| – | – | 0.03% | 171 |
|
|
2023
Q4 | $688K | Hold |
11,500
| – | – | 0.03% | 169 |
|
|
2023
Q3 | $437K | Buy |
11,500
+1,500
| +15% | +$57.1K | 0.02% | 198 |
|
|
2023
Q2 | $911K | Hold |
10,000
| – | – | 0.04% | 138 |
|
|
2023
Q1 | $660K | Hold |
10,000
| – | – | 0.03% | 164 |
|
|
2022
Q4 | $517K | Hold |
10,000
| – | – | 0.02% | 192 |
|
|
2022
Q3 | $683K | Hold |
10,000
| – | – | 0.03% | 164 |
|
|
2022
Q2 | $452K | Hold |
10,000
| – | – | 0.02% | 215 |
|
|
2022
Q1 | $508K | Hold |
10,000
| – | – | 0.02% | 216 |
|
|
2021
Q4 | $473K | Buy |
+10,000
| New | +$473K | 0.02% | 231 |
|